Kerri D Becktell, MD

• Milwaukee Campus-Children's Wisconsin
  8915 W. Connell Court
  Milwaukee, WI 53226

I strive to provide thoughtful, comprehensive and patient centered care to all patients that I see in both the inpatient and outpatient settings. I have two specialties within pediatric oncology: providing care for newly diagnosed solid tumors and leading a multidisciplinary team who cares for children who have a genetic predisposition to cancer. This multidisciplinary clinic was created with the goal of provided genetic counseling/testing and follow up care to patients and their families who may have genetic changes that increase their risk of developing any type of pediatric cancer.

Education

• 2013, Michigan State University College of Human Medicine, MD

Residencies

• 2016, McGaw Med Ctr of Northwestern Univ - Pediatrics

Fellowships

• 2019, Medical College of Wisconsin - Pediatric Hematology, Oncology, BMT

Research

• Long- term outcomes for Osteosarcoma Survivors: A report from the Childhood Cancer Survivor Study (CCSS)
• Developmental Differences in Health Related Quality of Life Outcomes for Adolescent and Young Adult (AYA) Childhood Cancer Survivors.
• Primary Care Providers Self-Reported Comfort Level in Identifying and Managing Pediatric Cancer Predisposition Patient
• Impact of Multidisciplinary Clinical Program on compliance with recommended cancer surveillance guidelines in Cancer Predisposition Syndromes
• Fertility Preservation options for newly diagnosed Oncology patients

Refereed journal publications/original papers

1. Badaway, S, Becktell, K, Muller, W and Schneiderman, “Aspergillus thyroiditis: first antemortem case diagnosed by fine-needle aspiration culture in a pediatric stem cell transplant patient” J.  Transpl Infect Dis. 2016. Dec 17 (6): 868-71
2. Becktell K, Houser K, Burke MJ. “Epigenetic Therapy in a Patient with Down Syndrome and Refractory Acute Myeloid Leukemia” J Pediatr Hematol Oncol. 2018. April 17.
3. Ehrhardt,M, Chen Y, Sandlund J, Bluhm E, Hayashi R, Becktell K, Leisenring W, Metzger M, Ness K, Krull K, Oeffinger K, Gibson T,Cairo M, Gross T, Robison L, Armstrong G, Yasui Y, Hudson M and Mulrooney D.  “Late health outcomes following contemporary Lymphome Malin de Burkitt therapy for B-cell non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study” J Clin Oncol. 2019 Oct 1;37(28):2556-2570.
4. Becktell, K, Simpson, P, Schmidt, D, Anderson, L, Nichols, J, Phelan, R, Bingen, K. Developmental Differences in Health Related Quality of Life in Adolescent and Young Adult Cancer Survivors.  Qual Life Res. 2020 Apr 22.
5. Woodruff TK, Ataman-Millhouse, L, Acharya KS, Anazodo A, Anderson RA, Appiah L, Bader J, Becktell K, ….Zelinkski M, et al.  “A View from the past into our collective future: the oncofertility consortium vision statement.”.  J Assist Reprod Genet. 2021 Jan; 38(1):3-15
6. Barrie, R, Fishbein J, Lautz T,..Becktell K,..et al, “Inflammatory Myofibroblastic Tumor: A Mutli-institutional Study from the Pediatric Surgical Oncology Research Collaboration”. International Journal of Cancer. 2022 May 23

Books, chapters and reviews

1. Taraseviciute, A*, Broglie, L*, Phelan R, Bhatt, N, Becktell, K, Burke MJ. “What is the Role of Hematopoietic Cell Transplantation (HCT) for Pediatric Acute Lymphoblastic Leukemia (ALL) in the Age of Chimeric Antigen Receptor (CAR) T-cell Therapy ?”.  J Pediatr Hematol.  2019 07;41(5):337-344
2. Becktell, K, Berlyne, D, Pagliuca, S, Pierri F, Pommert, L, Prata P, Margolis, D, Reffault de Latour, R, Dufour, C, Pierri, F. “Aplastic Anemia & MDS International (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018”.  Leuk Res 2019 Mar 20:80:19-25
3. Phelan R, Eissa H, Becktell K, Bhatt N, Kudek M, Nuechterlein B, Pommert L, Tanaka R, Baker KS. “Upfront Therapies and Downstream Effects: Navigating Late Effects in Childhood Cancer Survivors in the Current Era”. Current Oncology Reports. 2019 11 25;21(12):104